nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—ESRRA—Metabolism—SLC16A8—age related macular degeneration	0.00306	0.00306	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00305	0.00305	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00294	0.00294	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—ELOVL4—age related macular degeneration	0.00292	0.00292	CbGpPWpGaD
Tamoxifen—ABCG2—HIF-2-alpha transcription factor network—VEGFA—age related macular degeneration	0.0029	0.0029	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00287	0.00287	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—NMNAT1—age related macular degeneration	0.0028	0.0028	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—ERCC6—age related macular degeneration	0.00269	0.00269	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00269	0.00269	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00264	0.00264	CbGpPWpGaD
Tamoxifen—CYP1A2—Melatonin metabolism and effects—APOE—age related macular degeneration	0.00264	0.00264	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—CCL2—age related macular degeneration	0.00259	0.00259	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00258	0.00258	CbGpPWpGaD
Tamoxifen—CYP2A6—NRF2 pathway—SQSTM1—age related macular degeneration	0.00257	0.00257	CbGpPWpGaD
Tamoxifen—EBP—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00255	0.00255	CbGpPWpGaD
Tamoxifen—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00251	0.00251	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—ELOVL4—age related macular degeneration	0.00244	0.00244	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00237	0.00237	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00236	0.00236	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00236	0.00236	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—SLC16A8—age related macular degeneration	0.00235	0.00235	CbGpPWpGaD
Tamoxifen—ESR1—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00233	0.00233	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.0023	0.0023	CbGpPWpGaD
Tamoxifen—EBP—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00225	0.00225	CbGpPWpGaD
Tamoxifen—FMO3—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.0021	0.0021	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.00207	0.00207	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—LIPC—age related macular degeneration	0.00207	0.00207	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—NMNAT1—age related macular degeneration	0.00206	0.00206	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00205	0.00205	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00205	0.00205	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00204	0.00204	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—LIPC—age related macular degeneration	0.00203	0.00203	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—CETP—age related macular degeneration	0.00199	0.00199	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—SLC16A8—age related macular degeneration	0.00197	0.00197	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—LIPC—age related macular degeneration	0.00196	0.00196	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—CETP—age related macular degeneration	0.00196	0.00196	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—CETP—age related macular degeneration	0.00189	0.00189	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00181	0.00181	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—ELOVL4—age related macular degeneration	0.0018	0.0018	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.0018	0.0018	CbGpPWpGaD
Tamoxifen—ESR2—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00174	0.00174	CbGpPWpGaD
Tamoxifen—ABCG2—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.00171	0.00171	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—LIPC—age related macular degeneration	0.00168	0.00168	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00167	0.00167	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00166	0.00166	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—CETP—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Tamoxifen—CYP1A1—PPARA activates gene expression—CD36—age related macular degeneration	0.00161	0.00161	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00161	0.00161	CbGpPWpGaD
Tamoxifen—ABCB1—Allograft Rejection—C3—age related macular degeneration	0.00159	0.00159	CbGpPWpGaD
Tamoxifen—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—age related macular degeneration	0.00158	0.00158	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—LIPC—age related macular degeneration	0.00157	0.00157	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—NMNAT1—age related macular degeneration	0.00156	0.00156	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00154	0.00154	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00152	0.00152	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—CETP—age related macular degeneration	0.00151	0.00151	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—NMNAT1—age related macular degeneration	0.0015	0.0015	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00148	0.00148	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.00148	0.00148	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—SLC16A8—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—NMNAT1—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—ELOVL4—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—ERCC6—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—NMNAT1—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—ELOVL4—age related macular degeneration	0.00131	0.00131	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00124	0.00124	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—NMNAT1—age related macular degeneration	0.00124	0.00124	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00122	0.00122	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00121	0.00121	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—LIPC—age related macular degeneration	0.0012	0.0012	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—CD36—age related macular degeneration	0.0012	0.0012	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—ELOVL4—age related macular degeneration	0.00119	0.00119	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—ELOVL4—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—CD36—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00117	0.00117	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RDH8—age related macular degeneration	0.00116	0.00116	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00116	0.00116	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—CETP—age related macular degeneration	0.00116	0.00116	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00115	0.00115	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—CD36—age related macular degeneration	0.00114	0.00114	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—SLC16A8—age related macular degeneration	0.0011	0.0011	CbGpPWpGaD
Tamoxifen—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—age related macular degeneration	0.00109	0.00109	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ELOVL4—age related macular degeneration	0.00108	0.00108	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—APOE—age related macular degeneration	0.00106	0.00106	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—SLC16A8—age related macular degeneration	0.00106	0.00106	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—APOE—age related macular degeneration	0.00104	0.00104	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RPE65—age related macular degeneration	0.00102	0.00102	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—LIPC—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—APOE—age related macular degeneration	0.001	0.001	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—NMNAT1—age related macular degeneration	0.000999	0.000999	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.000984	0.000984	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—NMNAT1—age related macular degeneration	0.000978	0.000978	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—NMNAT1—age related macular degeneration	0.000976	0.000976	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—CD36—age related macular degeneration	0.000976	0.000976	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—CETP—age related macular degeneration	0.000973	0.000973	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000968	0.000968	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—SLC16A8—age related macular degeneration	0.00096	0.00096	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—SLC16A8—age related macular degeneration	0.000952	0.000952	CbGpPWpGaD
Tamoxifen—ABCB1—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.000923	0.000923	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—NMNAT1—age related macular degeneration	0.000922	0.000922	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—CD36—age related macular degeneration	0.000908	0.000908	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	0.0009	0.0009	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ELOVL4—age related macular degeneration	0.000873	0.000873	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—SLC16A8—age related macular degeneration	0.000872	0.000872	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—APOE—age related macular degeneration	0.000861	0.000861	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ELOVL4—age related macular degeneration	0.000855	0.000855	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000854	0.000854	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ELOVL4—age related macular degeneration	0.000853	0.000853	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—NMNAT1—age related macular degeneration	0.000846	0.000846	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ABCA4—age related macular degeneration	0.00082	0.00082	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ELOVL4—age related macular degeneration	0.000806	0.000806	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—APOE—age related macular degeneration	0.000801	0.000801	CbGpPWpGaD
Tamoxifen—ABCB1—Allograft Rejection—VEGFA—age related macular degeneration	0.000799	0.000799	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—NMNAT1—age related macular degeneration	0.000755	0.000755	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000747	0.000747	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000746	0.000746	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—LIPC—age related macular degeneration	0.000744	0.000744	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ELOVL4—age related macular degeneration	0.000739	0.000739	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—NMNAT1—age related macular degeneration	0.000737	0.000737	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00073	0.00073	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000721	0.000721	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—CETP—age related macular degeneration	0.000717	0.000717	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RHO—age related macular degeneration	0.000714	0.000714	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—SLC16A8—age related macular degeneration	0.000704	0.000704	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000703	0.000703	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—CD36—age related macular degeneration	0.000698	0.000698	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—NMNAT1—age related macular degeneration	0.000694	0.000694	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—SLC16A8—age related macular degeneration	0.000689	0.000689	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—NMNAT1—age related macular degeneration	0.000688	0.000688	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—SLC16A8—age related macular degeneration	0.000688	0.000688	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000685	0.000685	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000661	0.000661	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ELOVL4—age related macular degeneration	0.00066	0.00066	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—SLC16A8—age related macular degeneration	0.00065	0.00065	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000644	0.000644	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ELOVL4—age related macular degeneration	0.000644	0.000644	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000621	0.000621	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—APOE—age related macular degeneration	0.000616	0.000616	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000611	0.000611	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ELOVL4—age related macular degeneration	0.000607	0.000607	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ELOVL4—age related macular degeneration	0.000602	0.000602	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—SLC16A8—age related macular degeneration	0.000596	0.000596	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00059	0.00059	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—NMNAT1—age related macular degeneration	0.000588	0.000588	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—CD36—age related macular degeneration	0.000585	0.000585	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—LIPC—age related macular degeneration	0.000561	0.000561	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000557	0.000557	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000547	0.000547	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—CETP—age related macular degeneration	0.000541	0.000541	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—LIPC—age related macular degeneration	0.00054	0.00054	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000538	0.000538	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—SLC16A8—age related macular degeneration	0.000532	0.000532	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—CETP—age related macular degeneration	0.000521	0.000521	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—SLC16A8—age related macular degeneration	0.000519	0.000519	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—APOE—age related macular degeneration	0.000516	0.000516	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ELOVL4—age related macular degeneration	0.000514	0.000514	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—LIPC—age related macular degeneration	0.000492	0.000492	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—SLC16A8—age related macular degeneration	0.000489	0.000489	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—LIPC—age related macular degeneration	0.000487	0.000487	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—SLC16A8—age related macular degeneration	0.000485	0.000485	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000476	0.000476	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—CETP—age related macular degeneration	0.000474	0.000474	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—CETP—age related macular degeneration	0.00047	0.00047	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00046	0.00046	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000454	0.000454	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—LIPC—age related macular degeneration	0.000447	0.000447	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000433	0.000433	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—CD36—age related macular degeneration	0.000431	0.000431	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CETP—age related macular degeneration	0.000431	0.000431	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—SLC16A8—age related macular degeneration	0.000414	0.000414	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000401	0.000401	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000397	0.000397	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000397	0.000397	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000395	0.000395	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000382	0.000382	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—APOE—age related macular degeneration	0.00038	0.00038	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000363	0.000363	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—LIPC—age related macular degeneration	0.00036	0.00036	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000354	0.000354	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—LIPC—age related macular degeneration	0.000353	0.000353	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—LIPC—age related macular degeneration	0.000352	0.000352	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00035	0.00035	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CETP—age related macular degeneration	0.000348	0.000348	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CETP—age related macular degeneration	0.00034	0.00034	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CETP—age related macular degeneration	0.00034	0.00034	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—LIPC—age related macular degeneration	0.000333	0.000333	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—CD36—age related macular degeneration	0.000325	0.000325	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000323	0.000323	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CETP—age related macular degeneration	0.000321	0.000321	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.00032	0.00032	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—CD36—age related macular degeneration	0.000313	0.000313	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000313	0.000313	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—LIPC—age related macular degeneration	0.000305	0.000305	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CETP—age related macular degeneration	0.000294	0.000294	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—APOE—age related macular degeneration	0.000287	0.000287	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000285	0.000285	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—CD36—age related macular degeneration	0.000285	0.000285	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—CD36—age related macular degeneration	0.000282	0.000282	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—APOE—age related macular degeneration	0.000276	0.000276	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000276	0.000276	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—LIPC—age related macular degeneration	0.000272	0.000272	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—LIPC—age related macular degeneration	0.000266	0.000266	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CETP—age related macular degeneration	0.000263	0.000263	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CD36—age related macular degeneration	0.000259	0.000259	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CETP—age related macular degeneration	0.000256	0.000256	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—APOE—age related macular degeneration	0.000251	0.000251	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—LIPC—age related macular degeneration	0.00025	0.00025	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—APOE—age related macular degeneration	0.000249	0.000249	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—LIPC—age related macular degeneration	0.000248	0.000248	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000244	0.000244	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CETP—age related macular degeneration	0.000242	0.000242	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CETP—age related macular degeneration	0.00024	0.00024	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—C3—age related macular degeneration	0.000231	0.000231	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—APOE—age related macular degeneration	0.000228	0.000228	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—APOE—age related macular degeneration	0.000215	0.000215	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—LIPC—age related macular degeneration	0.000212	0.000212	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KDR—age related macular degeneration	0.00021	0.00021	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CD36—age related macular degeneration	0.000209	0.000209	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CETP—age related macular degeneration	0.000205	0.000205	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CD36—age related macular degeneration	0.000205	0.000205	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CD36—age related macular degeneration	0.000204	0.000204	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CD36—age related macular degeneration	0.000193	0.000193	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—APOE—age related macular degeneration	0.000184	0.000184	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCL2—age related macular degeneration	0.000181	0.000181	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—APOE—age related macular degeneration	0.000181	0.000181	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—APOE—age related macular degeneration	0.00018	0.00018	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CD36—age related macular degeneration	0.000177	0.000177	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—APOE—age related macular degeneration	0.00017	0.00017	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—LIPC—age related macular degeneration	0.000164	0.000164	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CETP—age related macular degeneration	0.000158	0.000158	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CD36—age related macular degeneration	0.000158	0.000158	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—APOE—age related macular degeneration	0.000156	0.000156	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CD36—age related macular degeneration	0.000154	0.000154	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CD36—age related macular degeneration	0.000145	0.000145	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CD36—age related macular degeneration	0.000144	0.000144	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—APOE—age related macular degeneration	0.000139	0.000139	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—APOE—age related macular degeneration	0.000136	0.000136	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—APOE—age related macular degeneration	0.000128	0.000128	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—APOE—age related macular degeneration	0.000127	0.000127	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CD36—age related macular degeneration	0.000123	0.000123	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VEGFA—age related macular degeneration	0.000116	0.000116	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—APOE—age related macular degeneration	0.000109	0.000109	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CD36—age related macular degeneration	9.49e-05	9.49e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—APOE—age related macular degeneration	8.38e-05	8.38e-05	CbGpPWpGaD
